Jean Jacques Bienaime, CEO: Biomarin Pharmaceutical BMRN Sell · Filed 23/05/11

Trade details

Type: Insider sale
Amount: $2,030,526.45
Shares · price: 21,453 sh · $94.65 a share
Held after: 434,760 sh
Stock: Biomarin Pharmaceutical BMRN
Person: Jean Jacques BienaimeCEO
Trade date: 23/05/10
Filed: 23/05/11
Days to filing: 1 days

Sold 4.7% of holdings

Share of holding sold: 4.7%

Biomarin Pharmaceutical trades, last 26 weeks

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 23/04/10~23/06/09

Jean Jacques Bienaime's recent trades

Jean Jacques BienaimeDirector
Buy10b5-1 planKeros Therapeutics
Buy10b5-1 plan
Keros Therapeutics
KROS
$10.2K
1,000 sh
$10.2K
Filed 06/17
Traded 06/15
Jean Jacques BienaimeDirector
BuyImmunome
Buy
Immunome
IMNM
$116.9K
6,000 sh
$116.9K
Filed 06/09
Traded 06/05
Jean Jacques BienaimeDirector
BuyImmunome
Buy
Immunome
IMNM
$68.1K
3,500 sh
$68.1K
Filed 06/09
Traded 06/05
Jean Jacques BienaimeDirector
BuyImmunome
Buy
Immunome
IMNM
$19.3K
1,000 sh
$19.3K
Filed 06/09
Traded 06/05
Jean Jacques BienaimeDirector
SellImmunome
Sell
Immunome
IMNM
$194.1K
10,000 sh
$194.1K
Filed 06/09
Traded 06/05

Jean Jacques Bienaime, CEO — sold $2M of Biomarin Pharmaceutical BMRN · 4.7% of holdings · 10b5-1 plan | Whalegun